NeoGenomics Inc. Common Stock vs Ryanair Holdings plc — how do they compare? NeoGenomics Inc. Common Stock trades at $17 (market cap $2.17B), while Ryanair Holdings plc trades at $51.7 (market cap $25.64B). The key difference: Ryanair Holdings plc is far larger — about 11.8× NeoGenomics Inc. Common Stock's market cap, and Ryanair Holdings plc pays a 1.75% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Ryanair Holdings plc for 72 Days on average.
| NEO | RYAAY | |
|---|---|---|
Market Cap | $2.17B | $25.64B |
Volume | 1,615,943 | 2,272,403 |
Sector | Health | Industrials |
52-Week High | $19.91 | $73.82 |
52-Week Low | $7.19 | $51.33 |
Typical Hold Time | 0 Days | 72 Days |
Enterprise Value | $2.47B | $22.70B |
Dividend Yield | — | 1.75% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Ryanair Holdings (RYAAY) trades at $52.84, down 0.3% on the day, with a bearish technical signal despite attractive valuation metrics including a P/E of 12.86 and EV/EBITDA of 5.68. The company reported mixed Q2 2026 earnings with a slight miss on EPS expectations but maintains strong profitability with 12.13% net margins. Recent news highlights CEO commentary on potential airfare increases due to high oil prices and Boeing MAX 10 certification delays.
RYAAY presents a compelling value opportunity with strong fundamentals and analyst support (64.7% buy ratings), though near-term headwinds include fuel cost volatility and operational challenges. The stock's current bearish technical positioning near support levels may offer entry points for long-term investors seeking exposure to Europe's leading low-cost carrier.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →